Questcor Pharmaceuticals (NASDAQ:QCOR)

CAPS Rating: 3 out of 5

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.

Recs

0
Player Avatar houstcarr (< 20) Submitted: 1/7/2011 1:43:06 AM : Underperform Start Price: $15.42 QCOR Score: -165.57

earnings miss

Report this Post 2 Comments
Member Avatar houstcarr (< 20) Submitted: 1/11/2011 7:52:48 PM
Recs: 0

this company derives 99% of its sales from one product, and has only one customer...

Report this Post
Member Avatar ta2122 (90.54) Submitted: 2/9/2012 1:21:24 PM
Recs: 0

Still makes money... more money than the previous year. Earnings misses don't mean much if overall operations exceed what is expected.

Report this Post

Featured Broker Partners


Advertisement